13.09 15:15 | dpa-AFX: DaVita Appoints David Maughan As COO |
13.09 14:24 | dpa-AFX: *DAVITA SAYS MIKE STAFFIERI WILL STEP INTO ROLE OF COO EMERITUS |
13.09 14:24 | dpa-AFX: *DAVITA SAYS DAVID MAUGHAN WILL ASSUME COO ROLE, EFFECTIVE SEPTEMBER 15 |
08.08 15:18 | dpa-AFX: *DAVITA COMMENCES PRIVATE OFFERING OF $1.0 BLN OF ITS SENIOR NOTES DUE 2032 |
06.08 22:10 | dpa-AFX: *DAVITA Q2 REVENUES $3.19 BLN VS. $3 BLN LAST YEAR |
06.08 22:10 | dpa-AFX: *DAVITA Q2 EPS $2.50 VS. $1.91 YEAR AGO |
06.08 22:10 | dpa-AFX: *DAVITA Q2 NET INCOME TO CO. $222.68 MLN VS. $178.69 MLN PRIOR YEAR |
06.08 22:10 | dpa-AFX: DaVita Inc. Q2 Profit Increases, Beats Estimates |
06.08 21:01 | dpa-AFX: DaVita Q2 24 Earnings Conference Call At 5:00 PM ET |
15.07 09:08 | dpa-AFX: *FMC MIT -2% VON EINF 200-TAGE-LINIE ZURÜCK IN JÜNGSTE RANGE |
15.07 08:32 | dpa-AFX: *FMC BEI TG FAST -5%, DAVITA -0,6% GETAXT - BERICHT ÜBER FTC-UNTERSUCHUNG |
24.05 15:41 | dpa-AFX: *DAVITA +4,4% - STEIGEN WIEDER ÜBER 21-TAGE-LINIE |
24.05 14:01 | dpa-AFX: *DAVITA VORBÖRSLICH +4,3% NACH MELDUNG ZU OZEMPIC-NIERENSTUDIE |
24.05 13:41 | dpa-AFX: AKTIEN IM FOKUS: FMC, Fresenius und Davita ziehen an nach Ozempic-Nachricht |
24.05 13:41 | AKTIEN IM FOKUS: FMC, Fresenius und Davita ziehen an nach Ozempic-Nachricht |
24.05 13:36 | dpa-AFX: AKTIEN IM FOKUS: FMC, Fresenius und Davita ziehen an nach Ozempic-Nachricht |
13.05 15:02 | dpa-AFX: *DAVITA APPOINTS MADHU NARASIMHAN AS CHIEF INFORMATION OFFICER, EFFECTIVE JUNE 3 |
02.05 22:11 | dpa-AFX: DaVita Inc. Q1 Profit Increases, beats estimates |
02.05 22:08 | dpa-AFX: *DAVITA Q1 REVENUES $3.07 BLN VS. $2.88 BLN LAST YEAR |
02.05 22:08 | dpa-AFX: *DAVITA Q1 EPS $2.65 VS. $1.25 YEAR AGO |
|